Assessing Zealand Pharma (CPSE:ZEAL) Valuation As New Cambridge Research Hub Expands AI Drug Discovery [Yahoo! Finance]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Yahoo! Finance
Why Zealand Pharma's new Cambridge hub matters for shareholders Zealand Pharma (CPSE:ZEAL) is opening a major research hub in Cambridge, Massachusetts, which will become its primary U.S. base and a center for AI driven drug discovery and next generation molecule work. This move gives the company a foothold in one of the deepest biotech talent pools worldwide, with access to over 600 life sciences companies and leading academic institutions clustered in the greater Boston area. See our latest analysis for Zealand Pharma. Despite the Cambridge announcement, Zealand Pharma's 30 day share price return of 24.8% and 90 day share price return of 41.1% indicate momentum has cooled recently. However, the 3 year total shareholder return of 15.56% and 5 year total shareholder return of 41.82% still paint a more constructive long term picture. If this kind of AI driven drug discovery story interests you, it can be worth widening your search to other potential opportunities in healthcar
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE marketsPR Newswire
- Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE marketsPR Newswire
- Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development [Yahoo! Finance]Yahoo! Finance
- How AI Is Transforming Patient Health At Genentech [Forbes]Forbes
- Why The Roche Holding (SWX:ROG) Narrative Is Shifting On Mixed Pipeline Signals And Valuation [Yahoo! Finance]Yahoo! Finance